Bariatric Procedure Outperforms Semaglutide in Patients With Obesity, Fatty Liver A recent study was published comparing two treatments for people with obesity and a liver condition called metabolic dysfunction-associated steatotic liver disease (MASLD)
Use finasteride or dutasteride only as prescribed
Most trials are in Chinese and limited by small sample sizes, short follow-up periods, and heterogeneous protocols, including variation in acupoint selection, treatment duration, adjunctive techniques (e.g., electroacupuncture, moxibustion), and underlying TCM diagnoses
FDA-approved GLP-1 medications for weight management are indicated for adults with a BMI of 30 or greater, or a BMI of 27 or greater with at least one weight-related health condition
Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease
This article examines the evidence, appropriate clinical indications, potential risks, and NHS guidance on B12 treatment and weight management
